NCT02329288

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of NA-AION

Retrobulbar Triamcinolone Acetonide Injection in the Treatment of Nonarteritic Anterior Ischemic Optic Neuropathy

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Second Military Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

NAION produces an ischemic insult in the optic nerve head presumably due to the hypoperfusion of the short ciliary arteries that supply it. Intravenous injection of glucocorticoid have proven to be effective in treatment of Nonarteritic Anterior Ischemic Optic Neuropathy,but have some side effects. the investigators believe that offering them Retrobulbar Triamcinolone Acetonide Injection that might halt the progression of the visual acuity and visual field loss if our hypothesis is correct, would greatly improve their chances of avoiding blindness.

Conditions

• Triamcinolone Acetonide
• Optic Neuropathy, Ischemic

Interventions

Type	Name	Description
DRUG	Triamcinolone Acetonide
DRUG	placebo

Timeline

• Start date: 2015-05-01
• Primary completion: 2015-12-01
• Completion: 2016-01-01
• First posted: 2014-12-31
• Last updated: 2015-03-30